186 related articles for article (PubMed ID: 34834088)
1. Theoretical Exploring of a Molecular Mechanism for Melanin Inhibitory Activity of Calycosin in Zebrafish.
Tayier N; Qin NY; Zhao LN; Zeng Y; Wang Y; Hu G; Wang YQ
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834088
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory mechanisms of glabridin on tyrosinase.
Chen J; Yu X; Huang Y
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Nov; 168():111-117. PubMed ID: 27288962
[TBL] [Abstract][Full Text] [Related]
3. Acetazolamide Inhibits the Level of Tyrosinase and Melanin: An Enzyme Kinetic, In Vitro, In Vivo, and In Silico Studies.
Abbas Q; Raza H; Hassan M; Phull AR; Kim SJ; Seo SY
Chem Biodivers; 2017 Sep; 14(9):. PubMed ID: 28557244
[TBL] [Abstract][Full Text] [Related]
4. Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies.
Ali A; Ashraf Z; Rafiq M; Kumar A; Jabeen F; Lee GJ; Nazir F; Ahmed M; Rhee M; Choi EH
Med Chem; 2019; 15(7):715-728. PubMed ID: 30892163
[TBL] [Abstract][Full Text] [Related]
5. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation.
Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541
[TBL] [Abstract][Full Text] [Related]
6. Discovery of highly potent tyrosinase inhibitor, T1, with significant anti-melanogenesis ability by zebrafish in vivo assay and computational molecular modeling.
Chen WC; Tseng TS; Hsiao NW; Lin YL; Wen ZH; Tsai CC; Lee YC; Lin HH; Tsai KC
Sci Rep; 2015 Jan; 5():7995. PubMed ID: 25613357
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Human Tyrosinase Requires Molecular Motifs Distinctively Different from Mushroom Tyrosinase.
Mann T; Gerwat W; Batzer J; Eggers K; Scherner C; Wenck H; Stäb F; Hearing VJ; Röhm KH; Kolbe L
J Invest Dermatol; 2018 Jul; 138(7):1601-1608. PubMed ID: 29427586
[TBL] [Abstract][Full Text] [Related]
8. Tyrosinase inhibition and anti-melanin generation effect of cinnamamide analogues.
Ullah S; Park C; Ikram M; Kang D; Lee S; Yang J; Park Y; Yoon S; Chun P; Moon HR
Bioorg Chem; 2019 Jun; 87():43-55. PubMed ID: 30856375
[TBL] [Abstract][Full Text] [Related]
9. Highly potent tyrosinase inhibitor, neorauflavane from Campylotropis hirtella and inhibitory mechanism with molecular docking.
Tan X; Song YH; Park C; Lee KW; Kim JY; Kim DW; Kim KD; Lee KW; Curtis-Long MJ; Park KH
Bioorg Med Chem; 2016 Jan; 24(2):153-9. PubMed ID: 26706112
[TBL] [Abstract][Full Text] [Related]
10. Phloretin as both a substrate and inhibitor of tyrosinase: Inhibitory activity and mechanism.
Chen J; Li Q; Ye Y; Huang Z; Ruan Z; Jin N
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 226():117642. PubMed ID: 31614273
[TBL] [Abstract][Full Text] [Related]
11. Molecular inhibitory mechanism of dihydromyricetin on mushroom tyrosinase.
Chen J; Liu S; Huang Z; Huang W; Li Q; Ye Y
J Biomol Struct Dyn; 2018 Nov; 36(14):3740-3752. PubMed ID: 29067862
[TBL] [Abstract][Full Text] [Related]
12. Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity.
Rosa GP; Palmeira A; Resende DISP; Almeida IF; Kane-Pagès A; Barreto MC; Sousa E; Pinto MMM
Bioorg Med Chem; 2021 Jan; 29():115873. PubMed ID: 33242700
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis of Cinnamyl-paeonol derivatives with 1, 3-Dioxypropyl as link arm and screening of tyrosinase inhibition activity in vitro.
Tang K; Jiang Y; Zhang H; Huang W; Xie Y; Deng C; Xu H; Song X; Xu H
Bioorg Chem; 2021 Jan; 106():104512. PubMed ID: 33293056
[TBL] [Abstract][Full Text] [Related]
14. Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.
Abbas Q; Ashraf Z; Hassan M; Nadeem H; Latif M; Afzal S; Seo SY
Drug Des Devel Ther; 2017; 11():2029-2046. PubMed ID: 28740364
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory activity and mechanism of trilobatin on tyrosinase: kinetics, interaction mechanism and molecular docking.
Yu S; He M; Zhai Y; Xie Z; Xu S; Yu S; Xiao H; Song Y
Food Funct; 2021 Mar; 12(6):2569-2579. PubMed ID: 33625428
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Novel Synthetic Tyrosinase Inhibitor (
Bang E; Noh SG; Ha S; Jung HJ; Kim DH; Lee AK; Hyun MK; Kang D; Lee S; Park C; Moon HR; Chung HY
Molecules; 2018 Dec; 23(12):. PubMed ID: 30551624
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of calycosin isolated from the root of Astragalus membranaceus on melanin biosynthesis.
Kim JH; Kim MR; Lee ES; Lee CH
Biol Pharm Bull; 2009 Feb; 32(2):264-8. PubMed ID: 19182387
[TBL] [Abstract][Full Text] [Related]
18. Discovery and identification of potential anti-melanogenic active constituents of Bletilla striata by zebrafish model and molecular docking.
Luo Y; Wang J; Li S; Wu Y; Wang Z; Chen S; Chen H
BMC Complement Med Ther; 2022 Jan; 22(1):9. PubMed ID: 34996448
[TBL] [Abstract][Full Text] [Related]
19. Cinnamic acid derivatives linked to arylpiperazines as novel potent inhibitors of tyrosinase activity and melanin synthesis.
Romagnoli R; Oliva P; Prencipe F; Manfredini S; Germanò MP; De Luca L; Ricci F; Corallo D; Aveic S; Mariotto E; Viola G; Bortolozzi R
Eur J Med Chem; 2022 Mar; 231():114147. PubMed ID: 35114540
[TBL] [Abstract][Full Text] [Related]
20. A novel anti-melanogenic agent, KDZ-001, inhibits tyrosinase enzymatic activity.
Hwang KS; Yang JY; Lee J; Lee YR; Kim SS; Kim GR; Chae JS; Ahn JH; Shin DS; Choi TY; Bae MA
J Dermatol Sci; 2018 Feb; 89(2):165-171. PubMed ID: 29191393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
